Association Asks the Government to Equation Compulsory Licenses for Obesity Drugs

Observador

Correio da Manhã

View article

Reposted by

Correio da Manhã

Lean Right

Factuality

Ownership

The Association of Users argues that the SNS and the public interest justify compulsory licences for obesity medicines — and recalls that a generic has reduced diabetes costs 14 times.

The best project ever.

Factuality

Ownership

Estimates released in the context of the budget impact analysis point to a public expenditure of €46.8 million in the first year with a 15% share in medicines for obesity. If the share reached 90%, the charges could amount to about €2 billion.

Noticias ao Minuto

Factuality

Ownership

UMG argues that 15% participation in obesity drugs does not end the barriers to treatment and asks the government to assess compulsory licences.